These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 38783925)

  • 61. Prevalence of Multi-Drug Resistant
    Ali S; Khan MT; Khan AS; Mohammad N; Khan MM; Ahmad S; Noor S; Jabbar A; Daire C; Hassan F
    Pol J Microbiol; 2020; 69(2):1-5. PubMed ID: 32249555
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Use of GeneXpert Mycobacterium tuberculosis/rifampicin for rapid detection of rifampicin resistant Mycobacterium tuberculosis strains of clinically suspected multi-drug resistance tuberculosis cases.
    Guenaoui K; Harir N; Ouardi A; Zeggai S; Sellam F; Bekri F; Cherif Touil S
    Ann Transl Med; 2016 May; 4(9):168. PubMed ID: 27275481
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The role of epigenetics, bacterial and host factors in progression of Mycobacterium tuberculosis infection.
    Marimani M; Ahmad A; Duse A
    Tuberculosis (Edinb); 2018 Dec; 113():200-214. PubMed ID: 30514504
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Anti-Tuberculosis Potential of OJT008 against Active and Multi-Drug-Resistant Mycobacterium Tuberculosis: In Silico and In Vitro Inhibition of Methionine Aminopeptidase.
    Onyenaka C; Idowu KA; Ha NP; Graviss EA; Olaleye OA
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38138972
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Harnessing Biological Insight to Accelerate Tuberculosis Drug Discovery.
    de Wet TJ; Warner DF; Mizrahi V
    Acc Chem Res; 2019 Aug; 52(8):2340-2348. PubMed ID: 31361123
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Multi-drug resistant tuberculosis burden and risk factors: an update.
    Marahatta SB
    Kathmandu Univ Med J (KUMJ); 2010; 8(29):116-25. PubMed ID: 21209520
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Advances in nanotechnology-based carrier systems for targeted delivery of bioactive drug molecules with special emphasis on immunotherapy in drug resistant tuberculosis - a critical review.
    Singh J; Garg T; Rath G; Goyal AK
    Drug Deliv; 2016 Jun; 23(5):1676-98. PubMed ID: 26289212
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Rapid Detection of Extensive Drug Resistance by Xpert MTB/XDR Optimizes Therapeutic Decision-Making in Rifampin-Resistant Tuberculosis Patients.
    Chen X; Li R; Ge S; Li Y; Cai C; Weng T; Zhang Y; Jiang J; Feng Z; Chen Y; Zhang Y; Ma J; Persing DH; Chen J; Tang YW; Sun F; Zhang W
    J Clin Microbiol; 2023 Jun; 61(6):e0183222. PubMed ID: 37249422
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Recent progress in the drug development of coumarin derivatives as potent antituberculosis agents.
    Keri RS; Sasidhar BS; Nagaraja BM; Santos MA
    Eur J Med Chem; 2015 Jul; 100():257-69. PubMed ID: 26112067
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Genome wide approaches discover novel Mycobacterium tuberculosis antigens as correlates of infection, disease, immunity and targets for vaccination.
    Coppola M; Ottenhoff TH
    Semin Immunol; 2018 Oct; 39():88-101. PubMed ID: 30327124
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Medicinal Plants as Therapeutic Alternatives to Combat
    Gautam S; Qureshi KA; Jameel Pasha SB; Dhanasekaran S; Aspatwar A; Parkkila S; Alanazi S; Atiya A; Khan MMU; Venugopal D
    Antibiotics (Basel); 2023 Mar; 12(3):. PubMed ID: 36978408
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Host-directed therapy against mycobacterium tuberculosis infections with diabetes mellitus.
    Zhao L; Fan K; Sun X; Li W; Qin F; Shi L; Gao F; Zheng C
    Front Immunol; 2023; 14():1305325. PubMed ID: 38259491
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Biapenem, a Carbapenem Antibiotic, Elicits Mycobacteria Specific Immune Responses and Reduces the Recurrence of Tuberculosis.
    Pahuja I; Verma A; Ghoshal A; Mukhopadhyay S; Kumari A; Shaji A; Chaturvedi S; Dwivedi VP; Bhaskar A
    Microbiol Spectr; 2023 Aug; 11(4):e0085823. PubMed ID: 37272833
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Barriers to tuberculosis treatment adherence in high-burden tuberculosis settings in Ashanti region, Ghana: a qualitative study from patient's perspective.
    Appiah MA; Arthur JA; Gborgblorvor D; Asampong E; Kye-Duodu G; Kamau EM; Dako-Gyeke P
    BMC Public Health; 2023 Jul; 23(1):1317. PubMed ID: 37430295
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Important role of DNA methylation hints at significant potential in tuberculosis.
    Qin Y; Li T; An P; Ren Z; Xi J; Tang B
    Arch Microbiol; 2024 Mar; 206(4):177. PubMed ID: 38494532
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Berbamine promotes macrophage autophagy to clear
    Zhang S; Zhou X; Ou M; Fu X; Lin Q; Tao X; Wang Z; Liu A; Li G; Xu Y; Zhang G
    mBio; 2023 Aug; 14(4):e0027223. PubMed ID: 37382506
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Host Directed Therapies for Tuberculosis: Futures Strategies for an Ancient Disease.
    Palucci I; Delogu G
    Chemotherapy; 2018; 63(3):172-180. PubMed ID: 30032143
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Genetic mechanisms of co-emergence of INH-resistant
    Tafess K; Ng TT-L; Tam KK-G; Leung KS-S; Leung JS-L; Lee L-K; Lao HY; Chan CT-M; Yam W-C; Wong SSY; Lau TC-K; Siu GK-H
    Microbiol Spectr; 2024 Apr; 12(4):e0213323. PubMed ID: 38466098
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Resistance and tolerance of Mycobacterium tuberculosis to antimicrobial agents-How M. tuberculosis can escape antibiotics.
    Li H; Yuan J; Duan S; Pang Y
    WIREs Mech Dis; 2022 Nov; 14(6):e1573. PubMed ID: 35753313
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Managing TB in the 21st century: existing and novel drug therapies.
    Guy ES; Mallampalli A
    Ther Adv Respir Dis; 2008 Dec; 2(6):401-8. PubMed ID: 19124385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.